Cognition Therapeutics, Inc. (CGTX) Income Annual - Discounting Cash Flows
CGTX
Cognition Therapeutics, Inc.
CGTX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
Report Filing 2025-11-06 2025-03-20 2024-03-26 2023-03-23 2022-03-30 2020-12-31 2019-12-31
Revenue 0 0 0 0 0 0 0
Cost of Revenue 0.061 0 0 0.235 0 0.098 0.081
Gross Profit -0.061 0 0 -0.235 0 -0.098 -0.081
Operating Expenses 44.79 53.97 50.72 43.32 28.6 17.31 17.75
Research & Development 34.19 41.68 37.2 30.32 18.57 12.89 14.38
Selling, General and Administrative 10.66 12.29 13.53 13.23 10.03 4.52 3.45
Other Operating Expenses -0.061 0 0 -0.235 0 -0.098 -0.081
Operating Income -44.85 -53.97 -50.72 -43.55 -28.6 -17.41 -17.83
Net Non-Operating Interest -0.013 -0.025 0.027 22.19 16.55 9.1 12.14
Interest Income 0 0 0.027 22.22 17.45 10.86 13.16
Interest Expense 0.013 0.025 0 0.028 0.893 1.75 1.02
Equity & Other Income/(Expense) 16.88 20.02 24.91 -0.035 0.328 0.464 0.849
Income Before Tax -27.99 -33.97 -25.79 -21.4 -11.72 -7.84 -4.84
Income Tax Expense 0 0 0 -22.15 0 0 0
Income Attributable to Non-Controlling Interest 0 0 0 0 0 2.23 2.11
Net Income -27.99 -33.97 -25.79 0.757 -11.72 -10.07 -6.95
Depreciation and Amortization 0.238 0.266 0.252 0.235 0.093 0.098 0.081
EBITDA -44.61 -53.7 -50.47 -43.32 -28.5 -17.31 -17.75
Earnings Per Share (EPS) -0.483 -0.85 -0.86 -0.74 -0.73 -0.55 -0.32
Diluted Earnings Per Share -0.483 -0.85 -0.86 -0.74 -0.73 -0.55 -0.32
Weighted Average Shares Outstanding 77.95 39.73 29.99 28.99 22.23 21.94 21.94
Diluted Weighted Average Shares Outstanding 77.95 39.73 30.03 28.99 22.23 21.94 21.94
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program